Guidelines on surfactant treatment

Prenatal and Neonatal Medicine

Volumn 6, Issue 6, 2001, Pages 374-378

  Bevilacqua, G ^a   Goelz, R ^a   Halliday, H L ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; SURFACTANT; SURFACTANT ASSOCIATED PROTEIN;

DRUG COST; DRUG FORMULATION; FEMALE; HUMAN; INFANT; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEONATOLOGY; NEWBORN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 0035702330     PISSN: 13598635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Treatment strategies in Europe for neonatal pulmonary morbidity using surfactant and postnatal corticosteroids
2. Trend in mortality from respiratory distress syndrome in the United States, 1970-1999
3. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: An international randomized clinical trial
4. Early versus delayed neonatal administration of a synthetic surfactant - The judgement of OSIRIS
5. Surfactant evolving issues
6. Surfactant replacement therapy for respiratory distress syndrome
7. Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial)
8. Clinical trials of surfactant therapy in the newborn
9. Surfactant replacement therapy for meconium aspiration syndrome
10. Treatment of severe meconium aspiration syndrome with porcine surfactant
11. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection
12. Surfactant lavage for meconium aspiration syndrome: A pilot study
13. New developments in intra-amniotic surfactant therapy
14. Natural vs. synthetic surfactants in neonatal respiratory distress syndrome
15. Synthetic or natural surfactants
16. Synthetic surfactants to treat neonatal lung disease
17. Surfactant therapy in the newborn
18. Randomised, placebo controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity
19. Intra-amniotic surfactant for prevention of neonatal respiratory distress syndrome (NRDS): Rationale and personal experience
20. Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf
21. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants (Cochrane Review)
22. Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: A multicentre prospective randomised trial
23. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation
24. Systemic review of prophylactic vs. rescue surfactant
25. Porcine surfactant replacement therapy in newborns of 25-31 weeks' gestation: A randomized, multicentre trial of prophylaxis versus rescue with multiple low doses
26. Randomised multicentre trial of treatment with porcine natural surfactant for moderately severe neonatal respiratory distress syndrome
27. Randomized clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome
28. Early versus late surfactant replacement therapy in severe respiratory distress syndrome
29. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation
30. A 2-years follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome
31. Developmental outcome in extremely premature infants: Impact of surfactant
32. Double-blind developmental evaluation at 1-year corrected age of 597 premature infants with birth weights from 500 to 1350 grams enrolled in three placebo-controlled trials of prophylactic surfactant
33. Pulmonary mechanics in the first two years of life of premature babies with neonatal respiratory distress syndrome (NRDS)
34. Pulmonary mechanics after surfactant replacement for neonatal respiratory distress syndrome